Is Zentalis Pharmaceuticals, Inc. (ZNTL) a Buy, Sell, or Hold?
NASDAQ : ZNTL
Zentalis Pharmaceuticals, Inc. — Analyst Ratings
$4.22 USD
-$0.78 (-15.6%)
- Volume
- 1.58M
- Average Volume
- 1.17M
- Market Capitalization
- $300.41M
- P/E Ratio
- -1.72
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $6.95
- Year Low
- $1.21
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.82
Analyst Consensus Summary
Consensus Rating
Strong Sell
12 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-57.8%
vs Current Price
Price Target
$10.00
Average TargetPrice Target Range
Lowest Target
$5.00
-15.6% DOWNSIDE
Average Target
$10.00
Median Estimate
Highest Target
$10.00
-57.8% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 12
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 8 | 4 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Andrew Fein | $10 | $4.14 | 2026-05-22 06:56 AM | 141.5% |
| Leerink Partners | Andrew Berens | $2 | $1.32 | 2025-11-11 04:50 AM | 51.5% |
| Jefferies | Akash Tewari | $6 | $4.305 | 2024-06-18 10:17 AM | 39.4% |
| Morgan Stanley | Matthew Harrison | $8 | $4.14 | 2024-06-18 09:32 AM | 93.2% |
| Stifel Nicolaus | Bradley Canino | $10 | $5.39 | 2024-06-18 07:46 AM | 85.5% |
| Wedbush | Robert Driscoll | $4 | $5.7 | 2024-06-18 06:45 AM | -29.8% |
| Stifel Nicolaus | Bradley Canino | $32 | $12.43 | 2024-05-07 12:31 PM | 157.4% |